Speakers: Lauren Forsythe, PharmD, DICVP and Mike Juliano, RPh, J.D.
Total RACE-Approved CE Credit Hours: 1 hour
Presentation approved by AAVSB in jurisdictions that recognize RACE approval
The FDA has released the final version of GFI #256. This guidance document outlines when it is appropriate to prepare compounded medications utilizing bulk chemicals and the additional documentation that is required. While the beginning of enforcement was scheduled for October of 2022, it has been delayed until 2023 to provide additional time for compliance and education.
This 1 hour CE session will review the guidance requirements, the risks it is designed to minimize, and practical considerations for how you can comply in daily practice.
Reserve your spot and join us for an informative and helpful webinar, Do You Know What’s In A Compound? New FDA Guidance Says You Should.
Dr. Forsythe is a Clinical Assistant Professor of Pharmacy and the Pharmacy Service Head at the University of Illinois Veterinary Teaching Hospital. She is also a diplomat of the International College of Veterinary Pharmacists. Dr. Forsythe graduated from the University of Findlay, College of Pharmacy in 2015 and completed her veterinary pharmacy residency at Purdue’s Veterinary Teaching Hospital. Following the completion of her residency, Dr. Forsythe spent three years at the UC Davis Veterinary Medical Teaching Hospital as a Clinical Pharmacist before coming to UIUC in 2019.
Mike Juliano is an attorney and licensed pharmacist. He works for Stokes Healthcare Inc. which operates both a 503A traditional compounding pharmacy and a 503B outsourcing facility. Mike assists with ensuring that each facility complies with federal regulations as well as the myriad of state regulations applicable to both facilities, which are licensed in almost every state in the country.
All information provided on this site is for educational purposes only. Every effort has been made to provide accurate and up-to-date information. It is not intended to be used as medical advice for the diagnosis of health problems nor does it include all possible uses, actions, safety measures, side effects, or interactions. Please consult a healthcare provider or veterinarian for the diagnosis and treatment of any health conditions. Epicur Pharma® manufactured veterinary orders are for non food chain animals only. Epicur Pharma® is registered with the FDA as an outsourcing facility.
© 2020 Epicur Pharma®
Epicur Pharma®
8000 Commerce Parkway, Ste. 600
Mount Laurel, NJ 08054
AAHA Strategic Alliance Program
Bronze Member
VHMA Business Alliance
Gold Partner